People Iris Hagemans

Contact

Iris Hagemans MSc

contact

Iris Hagemans PhD candidate

The goal of Iris Hagemans' current project is to generate optimized molecular immune checkpoint-inhibitory approaches.

read more

Iris Hagemans PhD candidate

Recently, a new type of treatment has become available, which blocks immunosuppressive signals generated by tumor cells. Breakthroughs in the field of these checkpoint inhibitors have even been called the scientific breakthrough of the year 2013. However, the systemic character of this type of therapy has a significant drawback: it elicits auto-immune reactions. The goal of the current project is to generate optimized molecular immune checkpoint-inhibitory approaches.

Field of study

Tumour Immunology Lab

Radboud Institute for Molecular Life Sciences

Our main aim is to achieve a greater understanding of the molecular mechanisms of disease. By integrating fundamental and clinical research, we obtain multifaceted knowledge of (patho)physiological processes. read more